GIANNOTTA, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 85
NA - Nord America 60
AS - Asia 25
AF - Africa 5
OC - Oceania 3
SA - Sud America 2
Totale 180
Nazione #
IT - Italia 57
US - Stati Uniti d'America 55
SG - Singapore 11
GB - Regno Unito 7
IR - Iran 6
CA - Canada 5
FR - Francia 4
IE - Irlanda 4
IN - India 3
NO - Norvegia 3
CO - Colombia 2
DE - Germania 2
EG - Egitto 2
FI - Finlandia 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AU - Australia 1
BE - Belgio 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IL - Israele 1
MA - Marocco 1
NL - Olanda 1
SE - Svezia 1
TR - Turchia 1
ZW - Zimbabwe 1
Totale 180
Città #
Turin 31
Ashburn 7
Dublin 4
Florence 4
La Habra 4
Los Angeles 4
New Malden 4
Palermo 4
Paris 4
Rome 4
Singapore 4
Edmonton 3
El Monte 3
New York 3
Alexandria 2
Ambler 2
Auckland 2
Baldissero d'Alba 2
Bogotá 2
Boston 2
Debrecen 2
Harringay 2
Lappeenranta 2
Pune 2
Tehran 2
Abidjan 1
Birmingham 1
Brussels 1
Casablanca 1
Central 1
Dallas 1
Fremont 1
Fubine 1
Guwahati 1
Hadera 1
Harare 1
Indianapolis 1
La Jolla 1
Las Vegas 1
Malo 1
Mannheim 1
Melbourne 1
Milan 1
Nepean 1
New Orleans 1
Noto 1
Nyköping 1
Olomouc 1
Oslo 1
Ostenfeld 1
Parsippany 1
Pedrengo 1
Toronto 1
Vezirkopru 1
Washington 1
Totale 135
Nome #
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells 94
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status 31
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT 20
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? 19
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA 12
MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS 10
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma 8
Totale 194
Categoria #
all - tutte 1.051
article - articoli 0
book - libri 0
conference - conferenze 123
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023129 0 0 0 0 0 5 30 22 21 29 16 6
2023/202455 6 9 8 4 4 9 3 0 0 2 3 7
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 194